These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26142627)

  • 1. Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents.
    Wang Z; Xia J; Cai F; Zhang F; Yang M; Bi S; Gui R; Li Y; Xia Y
    Colloids Surf B Biointerfaces; 2015 Oct; 134():40-6. PubMed ID: 26142627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide-functionalized hydrogels for sustained release of small molecule (aptamer) therapeutics.
    Agrawal NK; Allen P; Song YH; Wachs RA; Du Y; Ellington AD; Schmidt CE
    Acta Biomater; 2020 Jan; 102():315-325. PubMed ID: 31760222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-functionalized in situ injectable hydrogel for controlled protein release.
    Soontornworajit B; Zhou J; Zhang Z; Wang Y
    Biomacromolecules; 2010 Oct; 11(10):2724-30. PubMed ID: 20809645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy.
    Liu J; Liu H; Kang H; Donovan M; Zhu Z; Tan W
    Anal Bioanal Chem; 2012 Jan; 402(1):187-94. PubMed ID: 22052153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmable release of multiple protein drugs from aptamer-functionalized hydrogels via nucleic acid hybridization.
    Battig MR; Soontornworajit B; Wang Y
    J Am Chem Soc; 2012 Aug; 134(30):12410-3. PubMed ID: 22816442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive releasing of gold nanoparticles and liposomes from aptamer-functionalized hydrogels.
    El-Hamed F; Dave N; Liu J
    Nanotechnology; 2011 Dec; 22(49):494011. PubMed ID: 22101647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
    Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
    Shiao YS; Chiu HH; Wu PH; Huang YF
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity hydrogels for controlled protein release using nucleic acid aptamers and complementary oligonucleotides.
    Soontornworajit B; Zhou J; Snipes MP; Battig MR; Wang Y
    Biomaterials; 2011 Oct; 32(28):6839-49. PubMed ID: 21684002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy.
    Kang H; Liu H; Zhang X; Yan J; Zhu Z; Peng L; Yang H; Kim Y; Tan W
    Langmuir; 2011 Jan; 27(1):399-408. PubMed ID: 21126095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted VEGF-triggered release of an anti-cancer drug from aptamer-functionalized metal-organic framework nanoparticles.
    Chen WH; Yang Sung S; Fadeev M; Cecconello A; Nechushtai R; Willner I
    Nanoscale; 2018 Mar; 10(10):4650-4657. PubMed ID: 29465130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endonuclease-responsive aptamer-functionalized hydrogel coating for sequential catch and release of cancer cells.
    Li S; Chen N; Zhang Z; Wang Y
    Biomaterials; 2013 Jan; 34(2):460-9. PubMed ID: 23083933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-functionalized hydrogel diffraction gratings for the human thrombin detection.
    Wang X; Wang X
    Chem Commun (Camb); 2013 Jul; 49(53):5957-9. PubMed ID: 23715375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
    Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-functionalized superporous hydrogels for sequestration and release of growth factors regulated via molecular recognition.
    Battig MR; Huang Y; Chen N; Wang Y
    Biomaterials; 2014 Sep; 35(27):8040-8. PubMed ID: 24954732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.